[Abstract Only] Meta-analysis: SGLT2 Inhibitors Beneficial for the Prevention of Kidney Failure in Patients with Type 2 Diabetes

10 Sep, 2019 | 01:14h | UTC

SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis – The Lancet Diabetes & Endocrinology (link to abstract – $ for full-text)

Commentaries: Meta-analysis supports use of SGLT2 inhibitors to prevent kidney failure – Medicine Matters (free) AND New study confirms protective effect of diabetes drugs against kidney failure – George Institute for Global Health (free)

 

Join our WhatsApp group

Free Updates in All Specialties!

A daily update on the latest medical news, practice-changing trials and guidelines

Stay Updated in Your Specialty
No spam, just news
Unsubscribe with one click

 

Daily

 

Weekly or Less Often 
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •